|
2024
|
Invention
|
Substituted phenyl ethynyl pyrimidines as potent inhibitors of alphaviruses.
The present disclos... |
|
|
Invention
|
Substituted phenyl ethynyl pyrimidines as potent inhibitors of alphaviruses. The present disclosu... |
|
|
Invention
|
Pyrazolopyrimidines as antidotes for arsenicals. The present disclosure is concerned with pyrazol... |
|
|
Invention
|
Compounds for the treatment of cystic fibrosis. The present disclosure is concerned with piperidi... |
|
|
P/S
|
Medical and scientific research in the field of using genomic sequencing to improve health outcom... |
|
|
P/S
|
Providing public policy information in the field of improving healthcare for rural and underserve... |
|
|
Invention
|
Compounds for the treatment of acute and chronic kidney disease.
The present disclosure is conce... |
|
2023
|
Invention
|
Novel 2-pyrimidone analogs as potent antiviral agents against alphaviruses.
The present disclosu... |
|
|
Invention
|
6-aza-nucleoside prodrugs as antiviral agents for treating virus infections.
The present disclos... |
|
|
Invention
|
Identification of novel benzothiazones as tau-sh3 interaction inhibitors for the treatment of alz... |
|
|
Invention
|
2,5-aryl-thiazole analogs for the treatment of neurodegenerative diseases.
The present disclosur... |
|
|
Invention
|
Compounds for the treatment of acute and chronic kidney disease. The present disclosure is concer... |
|
|
Invention
|
Uracil derivatives for stimulating read-through of premature termination codons.
The present dis... |
|
|
Invention
|
Uracil derivatives for stimulating read-through of premature termination codons. egg., dystrophic... |
|
|
P/S
|
Business incubator services, namely, providing business management consulting and advisory servic... |
|
|
Invention
|
Development of potential antidotes for arsenicals. The present disclosure is concerned with purin... |
|
2022
|
Invention
|
Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of sars virus. The present ... |
|
|
Invention
|
2-pyrimidone analogs as potent antiviral agents against alphaviruses. The present disclosure is c... |
|
|
Invention
|
Substituted quinazoline sulfonamides as thioredoxin interacting protein (txnip) inhibitors. In on... |
|
|
Invention
|
Development of novel clofarabine analogs for cancer therapy. The present disclosure is concerned ... |
|
|
Invention
|
Compositions comprising 2'-deoxycytidine analogs and use thereof for the treatment of sickle cell... |
|
|
Invention
|
2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases. The present di... |
|
|
Invention
|
Modulators of programmed death-ligand-1.
The present disclosure is concerned with substituted ph... |
|
|
Invention
|
Modulators of programmed death-ligand-1. The present disclosure is concerned with substituted phe... |
|
2021
|
Invention
|
6-aza-nucleoside prodrugs as antiviral agents for treating virus infections. The present disclosu... |
|
|
Invention
|
Compounds for the treatment of acute and chronic kidney disease. e.ge.g., chronic kidney disease,... |
|
|
Invention
|
Enhanced therapeutic usage of a purine nucleoside phosphorylase or nuceloside hydrolase prodrug. ... |
|
|
Invention
|
Method and reactor to produce syngas.
Disclosed herein is a method and a reactor for the convers... |
|
|
Invention
|
Polymorphs of 5-aza-4'-thio-2'-deoxycytidine. The present disclosure provides crystalline polymor... |
|
|
Invention
|
Polymorphs of 5-aza-4'-thio-2-deoxycytidine. The present disclosure provides crystalline polymorp... |
|
|
Invention
|
Polymorophs of 5-aza-4′-thio-2′-deoxycytidine. The present disclosure provides crystalline polymo... |
|
|
Invention
|
Composition for treating blood cancer using 4′-thio-5-aza-2′-deoxycytidine and uses thereof. The ... |
|
|
Invention
|
Composition for treating blood cancer using 4'-thio-5-aza-2'-deoxycytidine and uses thereof. The ... |
|
|
Invention
|
Rna-binding protein multimerization inhibitors and methods of use thereof.
This disclosure provi... |
|
|
Invention
|
Rna-binding protein multimerization inhibitors and methods of use thereof. This disclosure provid... |
|
|
Invention
|
Contactless vital sign monitoring of multiple subjects in real-time. Systems and methods are prov... |
|
2020
|
Invention
|
Modulators of programmed death-ligand-1 and/or programmed death-ligand-2. The present disclosure ... |
|
|
Invention
|
2,4,7-substituted-7-deaza-2'-deoxy-2'-fluoroarabinosyl nucleoside and nucleotide pro-drugs and us... |
|
|
Invention
|
Thiarabine- and thiarabine prodrug-based treatments.
The present disclosure is concerned with co... |
|
2019
|
Invention
|
Piperazine-2,5-diones as tgf-beta inhibitors. The present disclosure is concerned with piperazine... |
|
|
Invention
|
4'-thio-nucleotide and -nucleoside prodrugs for the treatment of cancer.
The present disclosure ... |
|
2006
|
P/S
|
Research and development and consultation related thereto in the fields of drug discovery, precli... |
